Re: Hypertension as a biomarker of efficacy in patients with metastatic renal cell carcinoma treated with sunitinib

2011-10-19

Additional Metadata
Persistent URL	doi.org/10.1093/jnci/djr328, hdl.handle.net/1765/33255
Journal	National Cancer Institute. Journal (Print)
Organisation	Erasmus MC: University Medical Center Rotterdam
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	van den Meiracker, A., Danser, J., Sleijfer, S., & Kappers, M. (2011). Re: Hypertension as a biomarker of efficacy in patients with metastatic renal cell carcinoma treated with sunitinib. National Cancer Institute. Journal (Print), 103(20). doi:10.1093/jnci/djr328

Publication